Congress tightens money-laundering oversight, standardizes bank exams
H.R. 6829 — International Financial Access Improvements Act · Filed by Maxine Waters (D-CA) · Introduced Dec 17, 2025 · Referred to committee
Your members of Congress
Enter a ZIP to see where your representative and both senators stood on this bill.
Looked up on this device — your ZIP is never stored on our servers.
What it does
This bill amends U.S. foreign aid reporting requirements to strengthen anti-money-laundering oversight, particularly for narcotics-related financial crime. It requires the President to report on countries' progress in combating drug-money laundering, mandates the Treasury Secretary to consult with banking regulators on standardizing Bank Secrecy Act examinations across federal agencies, and directs submission of a separate money-laundering volume to Congress. The primary beneficiaries are law enforcement, financial regulators, and Congress—gaining better visibility into international compliance and domestic banking exam consistency.
Why we flagged it
The bill's core function is to strengthen reporting, oversight, and consistency in U.S. anti-money-laundering enforcement, particularly targeting narcotics-related financial crime. It is a regulatory transparency and coordination measure, not a substantive policy change.
What the text implies
- Standardizing Bank Secrecy Act exams may increase compliance costs for smaller financial institutions that currently face less rigorous scrutiny, potentially consolidating regulatory burden toward larger banks with greater compliance infrastructure.
- Requiring separate money-laundering volumes in foreign aid reports may shift diplomatic focus toward countries' financial crime records, potentially affecting aid allocation and bilateral relationships independent of traditional foreign policy considerations.
The full analysis lists 3 implications of this text.
Who stands to gain
Large financial institutions (compliance infrastructure advantage); Financial compliance software vendors; Regulatory consulting firms